Alimera Sciences Investor Relations Material
Latest events
Q4 2023
Alimera Sciences
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Alimera Sciences Inc
Access all reports
Alimera Sciences is a pharmaceutical company that develops and commercializes ophthalmic pharmaceuticals. We market ILUVEN, an intravitreal implant for the treatment of diabetic macular edema (DME) which is a disease of the retina that affects individuals with diabetes and leads to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. Our products can be purchased directly from our website or through authorized distributors. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia.
Latest articles
Remembering Daniel Kahneman: Transforming Psychology and Economics
Explore Daniel Kahneman's legacy in psychology and economics, highlighting his impact on decision-making and behavioral economics.
28 Mar 2024
Deere & Company: Shaping Agriculture & Construction Since 1837
Exploring Deere & Company: A global leader in agriculture & construction equipment since 1837.
28 Mar 2024
Jane Fraser: First Female Leader of a Major Wall Street Bank
Discover the journey of Jane Fraser, CEO of Citigroup and the first female leader of a major Wall Street bank.
28 Mar 2024
Ticker symbol
Country
🇺🇸 United States